Lisi SA
FII
ISIN FR0000050353 / Valor 494737
Lisi SA
UMushroom community rating:
About company
Lisi SA is a company that is well positioned in various markets, benefiting from the acquisition of orders for new high-value-added products and innovative solutions that cater to evolving customer needs. The company has implemented significant innovation programs and industrial investments in recent years, which are expected to drive positive momentum. Lisi SA aims to improve its key financial indicators, such as EBIT and Free Cash Flow, in an environment where inflationary pressure is expected to subside.
Summarized from source with an LLMView SourceSector: IndustrialsLatest Results (16.10.2025):
LISI SA reported its first half of 2025 financial results, demonstrating significant growth and improvement in key financial metrics. The company achieved record sales and enhanced profitability across all divisions, while confirming its annual targets despite currency headwinds.
Revenue Growth
Revenue for the first half of 2025 reached €978.8 million, marking an 8.3% increase compared to the same period in 2024. This growth was driven by a strong ramp-up in all segments of the aerospace market.
Significant EBIT Increase
EBIT surged by 77.1% to €95.6 million, reflecting strong operating leverage and improved industrial productivity across divisions.
Improved Operating Margin
The current operating margin increased by 3.8 points to 9.8%, driven by higher profitability in all sectors of the business.
Free Cash Flow Impact
Free cash flow stood at -€14.3 million, affected by a negative year-end currency effect estimated at -€31.9 million due to the weakening of the dollar against the euro.
Annual Targets Confirmed
Despite the currency challenges, LISI SA has confirmed its annual financial targets, maintaining confidence in its strategic direction and market performance.
Strategic Acquisition Discussions
On July 9, 2025, LISI SA entered into exclusive discussions with SK CAPITAL to acquire its LISI MEDICAL division, aiming to enhance its portfolio and market reach.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
2509 M
Market cap (USD)
25,534
Daily traded volume (Shares)
22.4 / 21.8
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
